Pharmaceutical

Frontotemporal Dementia (FTD) drugs in development, 2024

GlobalData tracks 119 drugs in development for Frontotemporal Dementia (FTD) by 92 companies/universities/institutes. The top development phase for Frontotemporal Dementia (FTD) is preclinical, with 66 drugs in that stage.

Aug 31, 2024 - 04:00
GlobalData tracks 119 drugs in development for Frontotemporal Dementia (FTD) by 92 companies/universities/institutes. The top development phase for Frontotemporal Dementia (FTD) is preclinical, with 66 drugs in that stage.
Read the original article

Tags:

Previous Article

Generalized Pustular Psoriasis (GPP) drugs in development, 2024

Next Article

Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency drugs in development, 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

When confronted with mysterious illness in college, ‘Chronically Catherine’ started writing

When confronted with mysterious illness in college, ‘Ch...

Apr 5, 2023

Boehringer Ingelheim advances weight loss drug to Phase III trials

Boehringer Ingelheim advances weight loss drug to Phase...

Aug 18, 2023

AbelZeta and AstraZeneca enter CAR-T cell therapy development deal

AbelZeta and AstraZeneca enter CAR-T cell therapy devel...

Dec 8, 2023